Phenmetrazine
Phenmetrazine
Phenmetrazine (pronounced: fen-met-ra-zeen) is a psychostimulant and anorectic drug that was first patented in the 1950s. It was used as an appetite suppressant in the treatment of obesity but was later withdrawn due to concerns about potential for abuse and addiction.
Etymology
The name "Phenmetrazine" is derived from its chemical structure, phenyl-ethyl-methylamine, with the suffix "-azine" added to denote its classification as an amine.
Pharmacology
Phenmetrazine acts primarily as a norepinephrine-dopamine releasing agent (NDRA). It stimulates the release of these neurotransmitters in the brain, which results in increased alertness, focus, and reduced appetite.
Related Terms
- Psychostimulant: A class of drugs that increase activity in the central nervous system and the body, leading to increased alertness, wakefulness, and locomotion.
- Anorectic: A drug that suppresses appetite, often used in the treatment of obesity.
- Obesity: A medical condition characterized by excess body fat, often associated with a variety of health problems.
- Norepinephrine-dopamine releasing agent (NDRA): A type of drug that increases the levels of norepinephrine and dopamine in the brain.
See Also
External links
- Medical encyclopedia article on Phenmetrazine
- Wikipedia's article - Phenmetrazine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski